Home - Products - Tyrosine Kinase - Src - 1-Naphthyl PP1 hydrochloride

1-Naphthyl PP1 hydrochloride

CAS No. 956025-47-1

1-Naphthyl PP1 hydrochloride( 1-NA-PP 1 hydrochloride )

Catalog No. M20768 CAS No. 956025-47-1

1-Naphthyl PP1 hydrochloride is a selective inhibitor of src family kinases v-Src.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 58 In Stock
10MG 88 In Stock
25MG 187 In Stock
50MG 305 In Stock
100MG 470 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    1-Naphthyl PP1 hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    1-Naphthyl PP1 hydrochloride is a selective inhibitor of src family kinases v-Src.
  • Description
    1-Naphthyl PP1 hydrochloride is a selective inhibitor of src family kinases v-Src .
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    1-NA-PP 1 hydrochloride
  • Pathway
    Tyrosine Kinase
  • Target
    Src
  • Recptor
    Src
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    956025-47-1
  • Formula Weight
    353.85
  • Molecular Formula
    C19H20ClN5
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:73 mg/mL (206.30 mM)
  • SMILES
    Cl.CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc12
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Bishop A C Ubersax J A Petsch D T et al. A chemical switch for inhibitor-sensitive alleles of any protein kinase[J]. Nature 2000 407(6802):395.
molnova catalog
related products
  • squarunkinA

    squarunkinA is a novel modulator of the UNC119-Cargo Interaction, potently and selectively inhibiting the binding of a myristoylated peptide representing the N-terminus of Src kinase to UNC119A

  • NCGC00262650

    NCGC00262650 is an inhibitor of AMA1-RON2 interaction and c-Src tyrosine kinase activity.

  • PP 3

    PP 3 is a Negative control for the Src kinase inhibitor PP 2.